FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gary G. Buterbaugh

Research Profile

Living Beings

Disorders

Procedures

Electroshock

Chemicals & Drugs

Anatomy

Physiology

Brain Chemistry

Co-author Network

Publications

TOP 3
Michael J Kubek; S M Knoblach; N A Sharif; David R Burt; Gary G. Buterbaugh; K S Fuson
Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures.
Gary G. Buterbaugh; G M Hudson
Estradiol replacement to female rats facilitates dorsal hippocampal but not ventral hippocampal kindled seizure acquisition.
Gary G. Buterbaugh
Estradiol replacement facilitates the acquisition of seizures kindled from the anterior neocortex in female rats.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gary G. Buterbaugh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1993: Michael J Kubek; S M Knoblach; N A Sharif; David R Burt; Gary G. Buterbaugh; K S Fuson
Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures.
Annals of neurology 1993;33(1):70-6.
1991: Gary G. Buterbaugh; G M Hudson
Estradiol replacement to female rats facilitates dorsal hippocampal but not ventral hippocampal kindled seizure acquisition.
Experimental neurology 1991;111(1):55-64.
1989: Gary G. Buterbaugh
Estradiol replacement facilitates the acquisition of seizures kindled from the anterior neocortex in female rats.
Epilepsy research 1989;4(3):207-15.
1989: J Kapur; Hillary B Michelson; Gary G. Buterbaugh; EW Lothman
Evidence for a chronic loss of inhibition in the hippocampus after kindling: electrophysiological studies.
Epilepsy research 1989;4(2):90-9.
1987: Gary G. Buterbaugh
Acquisition of amygdala-kindled seizures in female rats: relationship between the effect of estradiol and intra-amygdaloid electrode location.
Pharmacology, biochemistry, and behavior 1987;28(2):291-7.
1987: Gary G. Buterbaugh
Postictal events in amygdala-kindled female rats with and without estradiol replacement.
Experimental neurology 1987;95(3):697-713.
1987: Hillary B Michelson; Gary G. Buterbaugh
Alterations in beta-adrenergic receptor binding in partially and fully amygdala-kindled juvenile and adult rats.
Experimental neurology 1987;95(1):56-64.
1986: Gary G. Buterbaugh; Hillary B Michelson; D O Keyser
Status epilepticus facilitated by pilocarpine in amygdala-kindled rats.
Experimental neurology 1986;94(1):91-102.
1986: A C Hom; Gary G. Buterbaugh
Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats.
Epilepsia 1986;27(2):103-8.
1986: Gary G. Buterbaugh; Hillary B Michelson
Anticonvulsant properties of phencyclidine and ketamine.
NIDA research monograph 1986;64():67-79.
1985: Hillary B Michelson; Gary G. Buterbaugh
Amygdala kindling in juvenile rats following neonatal administration of 6-hydroxydopamine.
Experimental neurology 1985;90(3):588-93.
1985: K Kabat; Gary G. Buterbaugh; C U Eccles
Methylazoxymethanol as a developmental model of neurotoxicity.
Neurobehavioral toxicology and teratology 1985;7(5):519-25.
1985: S B Waller; Gary G. Buterbaugh
Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development.
Pharmacology, biochemistry, and behavior 1985;23(3):473-8.
1984: E M Sadler; Myron Weiner; Gary G. Buterbaugh
Activation of liver tryptophan oxygenase by hydrocortisone, hematin and tryptophan in streptozotocin-diabetic rats.
Life sciences 1984;34(14):1365-70.
1983: S B Waller; Gary G. Buterbaugh
Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
Pharmacology, biochemistry, and behavior 1983;19(6):973-8.
1983: E Sadler; Myron Weiner; Gary G. Buterbaugh
Effect of streptozotocin-induced diabetes on tryptophan oxygenase activity and brain tryptophan levels in rats.
Research communications in chemical pathology and pharmacology 1983;42(1):37-50.
1982: E D London; S B Waller; F J Vocci; Gary G. Buterbaugh
Age-dependent reduction in maximum electroshock convulsive threshold associated with decreased concentrations of brain monoamines.
Pharmacology, biochemistry, and behavior 1982;16(3):441-7.
1982: F J Vocci; Gary G. Buterbaugh
Hippocampal seizure discharge produced by systemic digitoxigenin is antagonized by reserpine or p-chlorophenylalanine.
Neuropharmacology 1982;21(1):95-8.
1980: F J Vocci; J M Rhody; E D London; Gary G. Buterbaugh
Regional brain 3H-digitoxigenin and monoamine content during the development of convulsions produced by system digitoxigenin.
Research communications in chemical pathology and pharmacology 1980;29(2):251-63.
1978: Gary G. Buterbaugh
Effect of drugs modifying central serotonergic function on the response of extensor and nonextensor rats to maximal electroshock.
Life sciences 1978;23(24):2393-404.
1978: E D London; Gary G. Buterbaugh
Modification of electroshock convulsive responses and thresholds in neonatal rats after brain monoamine reduction.
The Journal of pharmacology and experimental therapeutics 1978;206(1):81-90.
1977: Gary G. Buterbaugh
A role for central serotonergic systems in the pattern and intensity of the convulsive response of rats to electroshock.
Neuropharmacology 1977;16(10):707-9.
1977: Gary G. Buterbaugh; E D London
The relationship between magnitude of electroshock stimulation and the effects of digitoxigenin, pentylenetetrazol and brain monoamine reduction on electroshock convulsive thresholds.
Neuropharmacology 1977;16(9):617-23.
1975: P T Carroll; Gary G. Buterbaugh
High affinity choline transport in guinea pig brain and the effect of norepinephrine.
Journal of neurochemistry 1975;24(5):917-24.
1975: P T Carroll; Gary G. Buterbaugh
Regional differences in high affinity choline transport velocity in guinea-pig brain.
Journal of neurochemistry 1975;24(2):229-32.
1972: Myron Weiner; Gary G. Buterbaugh; D A Blake
Studies on the mechanism of inhibition of drug biotransformation by cyclic adenine nucleotides.
Research communications in chemical pathology and pharmacology 1972;4(1):37-50.
1972: Myron Weiner; Gary G. Buterbaugh; D A Blake
Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
Research communications in chemical pathology and pharmacology 1972;3(2):249-63.
1970: Gary G. Buterbaugh; J L Spratt
The possible role of brain monoamines in the acute toxicity of digitoxigenin.
The Journal of pharmacology and experimental therapeutics 1970;175(1):121-30.
1970: Gary G. Buterbaugh; J L Spratt
Observations on the possible role of central mechanisms in acute digitoxigenin toxicity.
Toxicology and applied pharmacology 1970;17(2):387-99.
1970: Gary G. Buterbaugh
The use of drugs in athletics.
Maryland state medical journal 1970;19(8):69-70.
1970: Gary G. Buterbaugh; J L Spratt
Effect of digitoxigenin in acute sublethal and lethal doses on biogenic amine content of whole rat brain.
Archives internationales de pharmacodynamie et de thérapie 1970;186(2):345-51.
1968: Gary G. Buterbaugh; J L Spratt
Effect of HC-3 on choline uptake by the isolated diaphragm.
The Journal of pharmacy and pharmacology 1968;20(6):488-90.
1968: Gary G. Buterbaugh; J L Spratt
Effects of hemicholinium on choline uptake in the isolated perfused rabbit heart.
The Journal of pharmacology and experimental therapeutics 1968;159(2):255-60.